# A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD

> **NCT00215436** · PHASE3 · COMPLETED · sponsor: **Dey** · enrollment: 345 (—)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Formoterol Fumarate

## Key facts

- **NCT ID:** NCT00215436
- **Lead sponsor:** Dey
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-09
- **Final completion:** 2006-09
- **Target enrollment:** 345 (—)
- **Last updated:** 2010-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00215436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00215436, "A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00215436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*